Docetaxel (RP 56976 or Taxotere), a semisynthetic drug belonging to th
e family of taxoids, is a new chemotherapeutic agent used in phase II
trials for boast, ovarian and lung cancer. We report 2 cases of subung
ual hemorrhages, which, to our knowledge, have yet to be cited in asso
ciation with the use of docetaxel. Although not incapacitating, the pa
tient should be made aware of the potential risk of this drug reaction
.